Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HOSPIRA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 28
  • 0 comments

FDA approve KETAMINE HYDROCHLORIDE

Comment Full text

APPCO

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 27
  • 0 comments

FDA approve VALGANCICLOVIR HYDROCHLORIDE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 27
  • 0 comments

FDA approve TAVABOROLE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 29
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

COREPHARMA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 26
  • 0 comments

FDA approve CHLORZOXAZONE

Comment Full text

YABAO PHARM

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 26
  • 0 comments

FDA approve CELECOXIB

Comment Full text

MSN PHARMACEUTICALS INC

  • FDA Approval
  • April 14, 2023, 17:57 UTC
  • 28
  • 0 comments

FDA approve PALBOCICLIB

Comment Full text

MYLAN SPECIALITY LP

  • FDA Approval
  • April 14, 2023, 11:43 UTC
  • 27
  • 0 comments

FDA approve LEVALBUTEROL HYDROCHLORIDE

Comment Full text

MICRO LABS

  • FDA Approval
  • April 14, 2023, 11:43 UTC
  • 26
  • 0 comments

FDA approve DALFAMPRIDINE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • April 14, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve COLESEVELAM HYDROCHLORIDE

Comment Full text
  • Previous
  • 842
  • 843
  • 844
  • 845
  • 846
  • Next

Search

News categories

  • Technical Exchange News(12137)
  • Event(5779)
  • SEC News(257801)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152347)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin